Colt Emerson’s debut season with the Seattle Mariners has not met expectations. The shortstop, who arrived in 2026 as the fifth-ranked prospect in baseball, posted a .190/.246/.335 batting line with a 34.4% strikeout rate across 69 games following his May 17 MLB debut. The team initially demoted him to Triple-A following Thursday’s game, but reversed that decision Friday by placing him on the 10-day injured list instead.
Emerson has been dealing with left wrist tendon inflammation and will consult with a specialist in the coming days. The possibility of season-ending surgery has not been excluded. The shortstop had sustained the initial wrist injury during early spring training and managed it throughout the season, including receiving a cortisone injection while in Triple-A in April. He occasionally took days off due to soreness but minimized the issue’s impact.
Mariners president of baseball operations Jerry Dipoto expressed frustration that Emerson did not more openly communicate the extent of his wrist problems earlier. Dipoto noted that Emerson had been managing the injury all year and characterized the player as exceptionally tough, but indicated the wrist issue likely contributed to Emerson’s subpar contact quality during his major league stint, with an 86.7-mph average exit velocity and 31.2% hard-hit rate compared to MLB averages of 88.8 mph and 38.7% respectively.
The Mariners called up infielder Brock Rodden to fill the roster spot. Rodden, 26, made his MLB debut Friday at shortstop, collecting one hit and two RBIs in four at-bats. Longtime shortstop JP Crawford has been unavailable since July 30 due to his own wrist injury, with his return timeline uncertain. Rodden will share shortstop duties with utility player Leo Rivas. The team is 57-66 on the season and positioned six games back of the Houston Astros in the AL West standings.
Article Attribution | Read More at Article Source
Article summary produced by Claude AI